HEADER    HYDROLASE/HYDROLASE INHIBITOR           26-OCT-11   3UCB              
TITLE     CRYSTAL STRUCTURE OF MULTIDRUG RESISTANT HIV-1 PROTEASE CLINICAL      
TITLE    2 ISOLATE PR20 IN COMPLEX WITH DARUNAVIR                               
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: PROTEASE;                                                  
COMPND   3 CHAIN: A, B;                                                         
COMPND   4 FRAGMENT: UNP RESIDUES 501-599;                                      
COMPND   5 ENGINEERED: YES;                                                     
COMPND   6 MUTATION: YES                                                        
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1;                 
SOURCE   3 ORGANISM_COMMON: HIV-1;                                              
SOURCE   4 ORGANISM_TAXID: 11676;                                               
SOURCE   5 GENE: POL;                                                           
SOURCE   6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;                                 
SOURCE   7 EXPRESSION_SYSTEM_TAXID: 469008;                                     
SOURCE   8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3);                                 
SOURCE   9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;                              
SOURCE  10 EXPRESSION_SYSTEM_PLASMID: PET11A                                    
KEYWDS    HYDROLASE-HYDROLASE INHIBITOR COMPLEX                                 
EXPDTA    X-RAY DIFFRACTION                                                     
AUTHOR    J.AGNISWAMY,S.CHEN-HSIANG,A.ANIANA,J.M.SAYER,J.M.LOUIS,I.T.WEBER      
REVDAT   3   13-SEP-23 3UCB    1       REMARK SEQADV HETSYN                     
REVDAT   2   17-OCT-12 3UCB    1       JRNL                                     
REVDAT   1   28-MAR-12 3UCB    0                                                
JRNL        AUTH   J.AGNISWAMY,C.H.SHEN,A.ANIANA,J.M.SAYER,J.M.LOUIS,I.T.WEBER  
JRNL        TITL   HIV-1 PROTEASE WITH 20 MUTATIONS EXHIBITS EXTREME RESISTANCE 
JRNL        TITL 2 TO CLINICAL INHIBITORS THROUGH COORDINATED STRUCTURAL        
JRNL        TITL 3 REARRANGEMENTS.                                              
JRNL        REF    BIOCHEMISTRY                  V.  51  2819 2012              
JRNL        REFN                   ISSN 0006-2960                               
JRNL        PMID   22404139                                                     
JRNL        DOI    10.1021/BI2018317                                            
REMARK   2                                                                      
REMARK   2 RESOLUTION.    1.38 ANGSTROMS.                                       
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : SHELXL-97                                            
REMARK   3   AUTHORS     : G.M.SHELDRICK                                        
REMARK   3                                                                      
REMARK   3  DATA USED IN REFINEMENT.                                            
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 1.38                           
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 10.00                          
REMARK   3   DATA CUTOFF            (SIGMA(F)) : 0.000                          
REMARK   3   COMPLETENESS FOR RANGE        (%) : NULL                           
REMARK   3   CROSS-VALIDATION METHOD           : THROUGHOUT                     
REMARK   3   FREE R VALUE TEST SET SELECTION   : RANDOM                         
REMARK   3                                                                      
REMARK   3  FIT TO DATA USED IN REFINEMENT (NO CUTOFF).                         
REMARK   3   R VALUE   (WORKING + TEST SET, NO CUTOFF) : 0.165                  
REMARK   3   R VALUE          (WORKING SET, NO CUTOFF) : 0.165                  
REMARK   3   FREE R VALUE                  (NO CUTOFF) : 0.223                  
REMARK   3   FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL                   
REMARK   3   FREE R VALUE TEST SET COUNT   (NO CUTOFF) : 1786                   
REMARK   3   TOTAL NUMBER OF REFLECTIONS   (NO CUTOFF) : 35715                  
REMARK   3                                                                      
REMARK   3  FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F).                     
REMARK   3   R VALUE   (WORKING + TEST SET, F>4SIG(F)) : NULL                   
REMARK   3   R VALUE          (WORKING SET, F>4SIG(F)) : NULL                   
REMARK   3   FREE R VALUE                  (F>4SIG(F)) : NULL                   
REMARK   3   FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : NULL                   
REMARK   3   FREE R VALUE TEST SET COUNT   (F>4SIG(F)) : NULL                   
REMARK   3   TOTAL NUMBER OF REFLECTIONS   (F>4SIG(F)) : NULL                   
REMARK   3                                                                      
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.                    
REMARK   3   PROTEIN ATOMS      : 1518                                          
REMARK   3   NUCLEIC ACID ATOMS : 0                                             
REMARK   3   HETEROGEN ATOMS    : 76                                            
REMARK   3   SOLVENT ATOMS      : 108                                           
REMARK   3                                                                      
REMARK   3  MODEL REFINEMENT.                                                   
REMARK   3   OCCUPANCY SUM OF NON-HYDROGEN ATOMS      : NULL                    
REMARK   3   OCCUPANCY SUM OF HYDROGEN ATOMS          : NULL                    
REMARK   3   NUMBER OF DISCRETELY DISORDERED RESIDUES : NULL                    
REMARK   3   NUMBER OF LEAST-SQUARES PARAMETERS       : NULL                    
REMARK   3   NUMBER OF RESTRAINTS                     : NULL                    
REMARK   3                                                                      
REMARK   3  RMS DEVIATIONS FROM RESTRAINT TARGET VALUES.                        
REMARK   3   BOND LENGTHS                         (A) : 0.010                   
REMARK   3   ANGLE DISTANCES                      (A) : 0.030                   
REMARK   3   SIMILAR DISTANCES (NO TARGET VALUES) (A) : NULL                    
REMARK   3   DISTANCES FROM RESTRAINT PLANES      (A) : NULL                    
REMARK   3   ZERO CHIRAL VOLUMES               (A**3) : NULL                    
REMARK   3   NON-ZERO CHIRAL VOLUMES           (A**3) : NULL                    
REMARK   3   ANTI-BUMPING DISTANCE RESTRAINTS     (A) : NULL                    
REMARK   3   RIGID-BOND ADP COMPONENTS         (A**2) : NULL                    
REMARK   3   SIMILAR ADP COMPONENTS            (A**2) : NULL                    
REMARK   3   APPROXIMATELY ISOTROPIC ADPS      (A**2) : NULL                    
REMARK   3                                                                      
REMARK   3  BULK SOLVENT MODELING.                                              
REMARK   3   METHOD USED: NULL                                                  
REMARK   3                                                                      
REMARK   3  STEREOCHEMISTRY TARGET VALUES : ENGH & HUBER                        
REMARK   3   SPECIAL CASE: NULL                                                 
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: NULL                                      
REMARK   4                                                                      
REMARK   4 3UCB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-OCT-11.                  
REMARK 100 THE DEPOSITION ID IS D_1000068574.                                   
REMARK 200                                                                      
REMARK 200 EXPERIMENTAL DETAILS                                                 
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION                  
REMARK 200  DATE OF DATA COLLECTION        : 08-OCT-08                          
REMARK 200  TEMPERATURE           (KELVIN) : 100                                
REMARK 200  PH                             : 4.6                                
REMARK 200  NUMBER OF CRYSTALS USED        : 1                                  
REMARK 200                                                                      
REMARK 200  SYNCHROTRON              (Y/N) : Y                                  
REMARK 200  RADIATION SOURCE               : APS                                
REMARK 200  BEAMLINE                       : 22-ID                              
REMARK 200  X-RAY GENERATOR MODEL          : NULL                               
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M                                  
REMARK 200  WAVELENGTH OR RANGE        (A) : 0.8                                
REMARK 200  MONOCHROMATOR                  : SI 220                             
REMARK 200  OPTICS                         : MIRRORS                            
REMARK 200                                                                      
REMARK 200  DETECTOR TYPE                  : CCD                                
REMARK 200  DETECTOR MANUFACTURER          : MARMOSAIC 300 MM CCD               
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : HKL-2000                           
REMARK 200  DATA SCALING SOFTWARE          : HKL-2000                           
REMARK 200                                                                      
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 35869                              
REMARK 200  RESOLUTION RANGE HIGH      (A) : 1.380                              
REMARK 200  RESOLUTION RANGE LOW       (A) : 50.000                             
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : 2.000                              
REMARK 200                                                                      
REMARK 200 OVERALL.                                                             
REMARK 200  COMPLETENESS FOR RANGE     (%) : 95.8                               
REMARK 200  DATA REDUNDANCY                : 6.000                              
REMARK 200  R MERGE                    (I) : 0.05400                            
REMARK 200  R SYM                      (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR THE DATA SET  : 27.3000                            
REMARK 200                                                                      
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.                                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.74                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 1.87                     
REMARK 200  COMPLETENESS FOR SHELL     (%) : 100.0                              
REMARK 200  DATA REDUNDANCY IN SHELL       : 6.50                               
REMARK 200  R MERGE FOR SHELL          (I) : 0.09300                            
REMARK 200  R SYM FOR SHELL            (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR SHELL         : 19.10                              
REMARK 200                                                                      
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH                              
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT        
REMARK 200 SOFTWARE USED: PHASER                                                
REMARK 200 STARTING MODEL: PDB ENTRY 2IEN                                       
REMARK 200                                                                      
REMARK 200 REMARK: NULL                                                         
REMARK 280                                                                      
REMARK 280 CRYSTAL                                                              
REMARK 280 SOLVENT CONTENT, VS   (%): 40.09                                     
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.05                     
REMARK 280                                                                      
REMARK 280 CRYSTALLIZATION CONDITIONS: 1.6M SODIUM CHLORIDE, 0.1M SODIUM        
REMARK 280  ACETATE, PH 4.6, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K    
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY                                            
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21                       
REMARK 290                                                                      
REMARK 290      SYMOP   SYMMETRY                                                
REMARK 290     NNNMMM   OPERATOR                                                
REMARK 290       1555   X,Y,Z                                                   
REMARK 290       2555   -X+1/2,-Y,Z+1/2                                         
REMARK 290       3555   -X,Y+1/2,-Z+1/2                                         
REMARK 290       4555   X+1/2,-Y+1/2,-Z                                         
REMARK 290                                                                      
REMARK 290     WHERE NNN -> OPERATOR NUMBER                                     
REMARK 290           MMM -> TRANSLATION VECTOR                                  
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS                            
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM             
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY                
REMARK 290 RELATED MOLECULES.                                                   
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   2 -1.000000  0.000000  0.000000       14.32000            
REMARK 290   SMTRY2   2  0.000000 -1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   2  0.000000  0.000000  1.000000       47.01600            
REMARK 290   SMTRY1   3 -1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   3  0.000000  1.000000  0.000000       32.83350            
REMARK 290   SMTRY3   3  0.000000  0.000000 -1.000000       47.01600            
REMARK 290   SMTRY1   4  1.000000  0.000000  0.000000       14.32000            
REMARK 290   SMTRY2   4  0.000000 -1.000000  0.000000       32.83350            
REMARK 290   SMTRY3   4  0.000000  0.000000 -1.000000        0.00000            
REMARK 290                                                                      
REMARK 290 REMARK: NULL                                                         
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC                           
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC                    
REMARK 350 SOFTWARE USED: PISA                                                  
REMARK 350 TOTAL BURIED SURFACE AREA: 4850 ANGSTROM**2                          
REMARK 350 SURFACE AREA OF THE COMPLEX: 10330 ANGSTROM**2                       
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -37.0 KCAL/MOL                        
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B                                  
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES                                       
REMARK 500                                                                      
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES              
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE               
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN               
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                 
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)              
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999                        
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996                     
REMARK 500                                                                      
REMARK 500  M RES CSSEQI ATM1   ATM2   ATM3                                     
REMARK 500    ARG A  41   CD  -  NE  -  CZ  ANGL. DEV. =  12.2 DEGREES          
REMARK 500    ARG B  57   NE  -  CZ  -  NH2 ANGL. DEV. =  -3.8 DEGREES          
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500    ALA B  67       46.18     39.87                                   
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 800                                                                      
REMARK 800 SITE                                                                 
REMARK 800 SITE_IDENTIFIER: AC1                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 017 A 201                 
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC2                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 017 B 202                 
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 3UF3   RELATED DB: PDB                                   
REMARK 900 RELATED ID: 3UFN   RELATED DB: PDB                                   
REMARK 900 RELATED ID: 3UHL   RELATED DB: PDB                                   
DBREF  3UCB A    1    99  UNP    P03367   POL_HV1BR      501    599             
DBREF  3UCB B    1    99  UNP    P03367   POL_HV1BR      501    599             
SEQADV 3UCB LYS A    7  UNP  P03367    GLN   507 ENGINEERED MUTATION            
SEQADV 3UCB PHE A   10  UNP  P03367    LEU   510 ENGINEERED MUTATION            
SEQADV 3UCB VAL A   13  UNP  P03367    ILE   513 ENGINEERED MUTATION            
SEQADV 3UCB VAL A   15  UNP  P03367    ILE   515 ENGINEERED MUTATION            
SEQADV 3UCB ASN A   30  UNP  P03367    ASP   530 ENGINEERED MUTATION            
SEQADV 3UCB ILE A   32  UNP  P03367    VAL   532 ENGINEERED MUTATION            
SEQADV 3UCB PHE A   33  UNP  P03367    LEU   533 ENGINEERED MUTATION            
SEQADV 3UCB ASP A   35  UNP  P03367    GLU   535 ENGINEERED MUTATION            
SEQADV 3UCB ILE A   36  UNP  P03367    MET   536 ENGINEERED MUTATION            
SEQADV 3UCB ASN A   37  UNP  P03367    SER   537 ENGINEERED MUTATION            
SEQADV 3UCB VAL A   47  UNP  P03367    ILE   547 ENGINEERED MUTATION            
SEQADV 3UCB LEU A   54  UNP  P03367    ILE   554 ENGINEERED MUTATION            
SEQADV 3UCB GLU A   58  UNP  P03367    GLN   558 ENGINEERED MUTATION            
SEQADV 3UCB VAL A   62  UNP  P03367    ILE   562 ENGINEERED MUTATION            
SEQADV 3UCB PRO A   63  UNP  P03367    LEU   563 ENGINEERED MUTATION            
SEQADV 3UCB ALA A   67  UNP  P03367    CYS   567 ENGINEERED MUTATION            
SEQADV 3UCB VAL A   71  UNP  P03367    ALA   571 ENGINEERED MUTATION            
SEQADV 3UCB VAL A   84  UNP  P03367    ILE   584 ENGINEERED MUTATION            
SEQADV 3UCB ASP A   88  UNP  P03367    ASN   588 ENGINEERED MUTATION            
SEQADV 3UCB THR A   89  UNP  P03367    LEU   589 ENGINEERED MUTATION            
SEQADV 3UCB MET A   90  UNP  P03367    LEU   590 ENGINEERED MUTATION            
SEQADV 3UCB ALA A   95  UNP  P03367    CYS   595 ENGINEERED MUTATION            
SEQADV 3UCB LYS B    7  UNP  P03367    GLN   507 ENGINEERED MUTATION            
SEQADV 3UCB PHE B   10  UNP  P03367    LEU   510 ENGINEERED MUTATION            
SEQADV 3UCB VAL B   13  UNP  P03367    ILE   513 ENGINEERED MUTATION            
SEQADV 3UCB VAL B   15  UNP  P03367    ILE   515 ENGINEERED MUTATION            
SEQADV 3UCB ASN B   30  UNP  P03367    ASP   530 ENGINEERED MUTATION            
SEQADV 3UCB ILE B   32  UNP  P03367    VAL   532 ENGINEERED MUTATION            
SEQADV 3UCB PHE B   33  UNP  P03367    LEU   533 ENGINEERED MUTATION            
SEQADV 3UCB ASP B   35  UNP  P03367    GLU   535 ENGINEERED MUTATION            
SEQADV 3UCB ILE B   36  UNP  P03367    MET   536 ENGINEERED MUTATION            
SEQADV 3UCB ASN B   37  UNP  P03367    SER   537 ENGINEERED MUTATION            
SEQADV 3UCB VAL B   47  UNP  P03367    ILE   547 ENGINEERED MUTATION            
SEQADV 3UCB LEU B   54  UNP  P03367    ILE   554 ENGINEERED MUTATION            
SEQADV 3UCB GLU B   58  UNP  P03367    GLN   558 ENGINEERED MUTATION            
SEQADV 3UCB VAL B   62  UNP  P03367    ILE   562 ENGINEERED MUTATION            
SEQADV 3UCB PRO B   63  UNP  P03367    LEU   563 ENGINEERED MUTATION            
SEQADV 3UCB ALA B   67  UNP  P03367    CYS   567 ENGINEERED MUTATION            
SEQADV 3UCB VAL B   71  UNP  P03367    ALA   571 ENGINEERED MUTATION            
SEQADV 3UCB VAL B   84  UNP  P03367    ILE   584 ENGINEERED MUTATION            
SEQADV 3UCB ASP B   88  UNP  P03367    ASN   588 ENGINEERED MUTATION            
SEQADV 3UCB THR B   89  UNP  P03367    LEU   589 ENGINEERED MUTATION            
SEQADV 3UCB MET B   90  UNP  P03367    LEU   590 ENGINEERED MUTATION            
SEQADV 3UCB ALA B   95  UNP  P03367    CYS   595 ENGINEERED MUTATION            
SEQRES   1 A   99  PRO GLN ILE THR LEU TRP LYS ARG PRO PHE VAL THR VAL          
SEQRES   2 A   99  LYS VAL GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR          
SEQRES   3 A   99  GLY ALA ASP ASN THR ILE PHE GLU ASP ILE ASN LEU PRO          
SEQRES   4 A   99  GLY ARG TRP LYS PRO LYS MET VAL GLY GLY ILE GLY GLY          
SEQRES   5 A   99  PHE LEU LYS VAL ARG GLU TYR ASP GLN VAL PRO ILE GLU          
SEQRES   6 A   99  ILE ALA GLY HIS LYS VAL ILE GLY THR VAL LEU VAL GLY          
SEQRES   7 A   99  PRO THR PRO VAL ASN VAL ILE GLY ARG ASP THR MET THR          
SEQRES   8 A   99  GLN ILE GLY ALA THR LEU ASN PHE                              
SEQRES   1 B   99  PRO GLN ILE THR LEU TRP LYS ARG PRO PHE VAL THR VAL          
SEQRES   2 B   99  LYS VAL GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR          
SEQRES   3 B   99  GLY ALA ASP ASN THR ILE PHE GLU ASP ILE ASN LEU PRO          
SEQRES   4 B   99  GLY ARG TRP LYS PRO LYS MET VAL GLY GLY ILE GLY GLY          
SEQRES   5 B   99  PHE LEU LYS VAL ARG GLU TYR ASP GLN VAL PRO ILE GLU          
SEQRES   6 B   99  ILE ALA GLY HIS LYS VAL ILE GLY THR VAL LEU VAL GLY          
SEQRES   7 B   99  PRO THR PRO VAL ASN VAL ILE GLY ARG ASP THR MET THR          
SEQRES   8 B   99  GLN ILE GLY ALA THR LEU ASN PHE                              
HET    017  A 201      76                                                       
HET    017  B 202      38                                                       
HETNAM     017 (3R,3AS,6AR)-HEXAHYDROFURO[2,3-B]FURAN-3-YL(1S,2R)-3-            
HETNAM   2 017  [[(4-AMINOPHENYL)SULFONYL](ISOBUTYL)AMINO]-1-BENZYL-2-          
HETNAM   3 017  HYDROXYPROPYLCARBAMATE                                          
HETSYN     017 DARUNAVIR; TMC114; UIC-94017                                     
FORMUL   3  017    2(C27 H37 N3 O7 S)                                           
FORMUL   5  HOH   *108(H2 O)                                                    
HELIX    1   1 GLY A   86  ILE A   93  1                                   8    
HELIX    2   2 GLY B   86  ILE B   93  1                                   8    
SHEET    1   A 4 GLN A   2  ILE A   3  0                                        
SHEET    2   A 4 THR B  96  ASN B  98 -1  O  LEU B  97   N  ILE A   3           
SHEET    3   A 4 THR A  96  ASN A  98 -1  N  ASN A  98   O  THR B  96           
SHEET    4   A 4 GLN B   2  ILE B   3 -1  O  ILE B   3   N  LEU A  97           
SHEET    1   B 8 LYS A  43  GLY A  49  0                                        
SHEET    2   B 8 GLY A  52  ILE A  66 -1  O  GLY A  52   N  GLY A  49           
SHEET    3   B 8 HIS A  69  VAL A  77 -1  O  VAL A  71   N  ILE A  64           
SHEET    4   B 8 ILE A  32  PHE A  33  1  N  PHE A  33   O  LEU A  76           
SHEET    5   B 8 VAL A  84  ILE A  85 -1  O  VAL A  84   N  ILE A  32           
SHEET    6   B 8 GLN A  18  LEU A  24  1  N  LEU A  23   O  ILE A  85           
SHEET    7   B 8 PHE A  10  VAL A  15 -1  N  VAL A  13   O  LYS A  20           
SHEET    8   B 8 GLY A  52  ILE A  66 -1  O  GLU A  65   N  LYS A  14           
SHEET    1   C 8 LYS B  43  GLY B  49  0                                        
SHEET    2   C 8 GLY B  52  ILE B  66 -1  O  GLU B  58   N  LYS B  43           
SHEET    3   C 8 HIS B  69  VAL B  77 -1  O  GLY B  73   N  VAL B  62           
SHEET    4   C 8 ILE B  32  PHE B  33  1  N  PHE B  33   O  LEU B  76           
SHEET    5   C 8 VAL B  84  ILE B  85 -1  O  VAL B  84   N  ILE B  32           
SHEET    6   C 8 GLN B  18  LEU B  24  1  N  LEU B  23   O  ILE B  85           
SHEET    7   C 8 PHE B  10  VAL B  15 -1  N  VAL B  13   O  LYS B  20           
SHEET    8   C 8 GLY B  52  ILE B  66 -1  O  GLU B  65   N  LYS B  14           
SITE     1 AC1 28 ARG A   8  ASP A  25  GLY A  27  ALA A  28                    
SITE     2 AC1 28 ASP A  29  ASN A  30  ILE A  32  GLY A  48                    
SITE     3 AC1 28 GLY A  49  ILE A  50  PRO A  81  VAL A  82                    
SITE     4 AC1 28 HOH A1065  HOH A1098  ARG B   8  ASP B  25                    
SITE     5 AC1 28 GLY B  27  ALA B  28  ASP B  29  ASN B  30                    
SITE     6 AC1 28 ILE B  32  GLY B  48  GLY B  49  ILE B  50                    
SITE     7 AC1 28 PRO B  81  VAL B  82  HOH B1045  HOH B1100                    
SITE     1 AC2 21 TRP A   6  GLY A  40  ARG A  41  TRP B  42                    
SITE     2 AC2 21 PRO B  44  LYS B  45  LYS B  55  VAL B  56                    
SITE     3 AC2 21 ARG B  57  ALA B  67  GLY B  68  VAL B  77                    
SITE     4 AC2 21 GLY B  78  PRO B  79  GLN B  92  ILE B  93                    
SITE     5 AC2 21 GLY B  94  HOH B1026  HOH B1056  HOH B1086                    
SITE     6 AC2 21 HOH B1102                                                     
CRYST1   28.640   65.667   94.032  90.00  90.00  90.00 P 21 21 21    8          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      0.034916  0.000000  0.000000        0.00000                         
SCALE2      0.000000  0.015228  0.000000        0.00000                         
SCALE3      0.000000  0.000000  0.010635        0.00000